IDEAYA Biosciences, Inc (NASDAQ:IDYA) Receives $36 73 Consensus Target Price from Analysts theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Free Report) shares were down 7.4% during trading on Tuesday following a weaker than expected earnings announcement. The stock traded as low as $43.61 and last traded at $43.65. Approximately 259,976 shares changed hands during mid-day trading, a decline of 75% from the average daily volume of 1,056,790 shares. […]
IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) – Equities research analysts at Capital One Financial issued their FY2028 earnings estimates for shares of IDEAYA Biosciences in a research report issued on Thursday, February 22nd. Capital One Financial analyst T. Chiang forecasts that the company will earn $4.54 per share for the year. Capital One Financial […]
IDEAYA Biosciences (NASDAQ:IDYA – Get Free Report) released its quarterly earnings results on Tuesday. The company reported ($0.52) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.47) by ($0.05), Briefing.com reports. The firm had revenue of $3.90 million during the quarter, compared to the consensus estimate of $8.84 million. IDEAYA Biosciences […]
IDEAYA Biosciences (NASDAQ:IDYA – Get Free Report) had its target price lifted by research analysts at Royal Bank of Canada from $43.00 to $53.00 in a report released on Wednesday, Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Royal Bank of Canada’s price target would indicate a potential upside of 19.42% […]